FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.
This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.
Ocado Group plc (LON:OCDO) will be hosting a meeting to discuss modelling of Ocado Group and the underlying operating segments on Wednesday 25th May 2022 at 3pm. Stephen Daintith, CFO,..
Barratt Developments PLC (LON:BDEV) has issued a trading update in respect of the period from 1 January 2022 to 1 May 2022. Comparatives are to the prior year equivalent period..
Shell plc (LON:SHEL) has announced an interim dividend in respect of the first quarter of 2022 of US$ 0.25 per ordinary share. Details relating to the first quarter 2022 interim..
Flutter Entertainment plc (LON:FLTR) has announced a trading update for three months ended 31 March 2022. Unaudited £m Q1 2022 Q1 2021 YoY % YoY % CC1 Average monthly players2 (‘000s) 8,855 7,672..
AstraZeneca plc (LON:AZN) supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), in combination with standard-of-care chemotherapy, has been accepted and granted Priority Review in the US for patients with locally..
Avast plc (LON:AVST), together with its subsidiaries, a leading global cybersecurity provider, has issued the following scheduled trading update for the first quarter of its current financial year, comprising the..
NatWest Group plc (LON:NWG) has announced its Q1 2022 Interim Management Statement. Chief Executive, Alison Rose, commented: “The world has changed considerably during the last three months. Our thoughts are..
AstraZeneca PLC (LON:AZN) has announced its first quarter 2022 results. Revenue and EPS summary Q1 2022 % Change $m Actual CER1 – Product Sales ..
AstraZeneca plc (LON:AZN) and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment of adult patients with unresectable or metastatic HER2-low..
Persimmon plc (LON:PSN) has provided an update on trading for the period from 1 January 2022 to date, ahead of its Annual General Meeting which is being held at 12.00..
Lloyds Banking Group plc (LON:LLOY) has announced its Q1 2022 Interim Management Statement. “In the first three months of 2022, we delivered solid financial performance, with strong income growth and..
M&G plc (LON:MNG) has announced that John Foley, Group Chief Executive, has informed the Board of his intention to retire. The Board will now initiate a process to appoint a..
B&M European Value Retail S.A. (LON:BME), the UK’s leading variety goods value retailer, today announced that Simon Arora, after over 17 years leading the business, intends to retire in 12..
B&M European Value Retail S.A. (LON:BME), the UK’s leading variety goods value retailer, has announced that Simon Arora, after over 17 years leading the business, intends to retire in 12..
Rentokil Initial PLC (LON:RTO) has announced first quarter trading update. (£m) Q1 2022 AER Growth AER Growth CER Ongoing Revenue 721.6 1.8% 1.8% Revenue 722.0 1.8% 1.8% Excluding disinfection Ongoing..
Glencore plc (LON:GLEN) has published its 2021 Sustainability Report, which is available on its website . Our 2021 Sustainability Report incorporates our ESG (environment, social and governance) data book, which..
Smurfit Kappa Group plc (LON:SKG) has continued to make significant progress on achieving its sustainability goals according to its 15th Sustainable Development Report (SDR). The report highlights the company’s progress..
SSE plc (LON:SSE) Renewables has entered into an agreement with Siemens Gamesa Renewable Energy (SGRE) to acquire its existing European renewable energy development platform for a consideration of €580m[1]. The..
AstraZeneca plc (LON:AZN) and Daiichi Sankyo have received notification of acceptance of the supplemental Biologics License Application (sBLA) of Enhertu (trastuzumab deruxtecan) for the treatment of adult patients in the..
GlaxoSmithKline plc (LON:GSK) has announced that the US Food and Drug Administration accepted the New Drug Application for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the potential..
